Primary Site >> Colorectal Cancer
Gene >> MAP3K14
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. PMID: 10557090 |
Ref: Thalidomide suppresses the interleukin 1beta-induced NFkappaB signaling pathway in colon cancer cells. PMID: 12485902 |
Ref: NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling. PMID: 15047705 |
Ref: TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. PMID: 15665513 |
Ref: Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins. PMID: 16714402 |
Ref: NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. PMID: 22503542 |
Ref: The identification of specific methylation patterns across different cancers. PMID: 25774687 Ref: Downregulation of miR-518a-3p activates the NIK-dependent NF-kappaB pathway in colorectal cancer. PMID: 25812680 |
Ref: NIBP impacts on the expression of E-cadherin, CD44 and vimentin in colon cancer via the NF-kappaB pathway. PMID: 27109343 Ref: Olfactomedin 1 negatively regulates NF-kappaB signalling and suppresses the growth and metastasis of colorectal cancer cells. PMID: 27555280 |
Ref: Knockdown of NIK and IKKbeta-Binding Protein (NIBP) Reduces Colorectal Cancer Metastasis through Down-Regulation of the Canonical NF-kappaBeta Signaling Pathway and Suppression of MAPK Signaling Mediated through ERK and JNK. PMID: 28125661 |
Ref: Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis. PMID: 29983872 |